This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
Janssen announces U.S. FDA approval Of STELARA® (ustekinumab) for the treatment of adolescents with moderate to severe plaque psoriasis
Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for STELARA® (ustekinumab) for the treatment of adolescents (12 years of age
